Showing 1 - 10 of 84
Background: Antibiotics have been overprescribed to treat infectious diseases and have generated antimicrobial resistances that reduce their effectiveness. Following the rationale behind the new paradigm of personalized medicine, point-of-care diagnostic testing (POCT) has been proposed to...
Persistent link: https://www.econbiz.de/10012607268
Persistent link: https://www.econbiz.de/10011654745
Background: Currently, personalised medicine is becoming more frequently used and many drug companies are including this strategy to gain market access for very specialized therapies. In this article, in order to understand the relationships between the health authority and the drug company when...
Persistent link: https://www.econbiz.de/10012162381
Persistent link: https://www.econbiz.de/10014328079
We analyze how a manufacturer with a brand-name drug close to patent expiration decides to launch a product-line extension (an upgrade through innovation) before it faces generic competition. There are two types of physicians: loyal physicians always prescribe first the product-line extension...
Persistent link: https://www.econbiz.de/10009355566
Persistent link: https://www.econbiz.de/10009247147
Persistent link: https://www.econbiz.de/10011299241
Persistent link: https://www.econbiz.de/10009658373
In this paper, we carry out a theoretical analysis of the strategic choice made by firms regarding the type of food they market when they face consumers who care about the healthy/unhealthy attributes of the product but incur in emotional/health costs when the food they consume has unhealthy...
Persistent link: https://www.econbiz.de/10009409546
Persistent link: https://www.econbiz.de/10010203536